TNFRSF17 and neoplasm: In contrast, no significant differences were observed in these hematologic parameters for the 18.5 MBq [131I]I-BCMA-Nb group, suggesting that effective tumor reduction enabled bone marrow recovery and restoration of normal hematopoietic function.